Trial intelligence / Profile preview

GamaSTAN PK and Safety in Healthy Subjects

NCT03351933Phase 4Completed

Sponsor
Grifols
Start
Oct 2017
Primary completion
Apr 2018
Modality
Biologic
Countries
1
01

Overview

A Phase 4 trial of immune globulin (human) in hepatitis A (HAV), sponsored by Grifols. Started Oct 2017; status: completed.

02

Drugs

immune globulin (human)
03

Conditions

hepatitis A (HAV)

Beyond the preview

Go deeper on NCT03351933.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03351933.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call